Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors (CROSBI ID 320324)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Sokhal, Balamrit Singh ; Matetić, Andrija ; Paul, Timir K. ; Velagapudi, Poonam ; Lambrinou, Ekaterini ; Figtree, Gemma A. ; Rashid, Muhammad ; Moledina, Saadiq ; Vassiliou, Vassilios S. ; Mallen, Christian et al. Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors // International journal of cardiology, 371 (2022), 391-396. doi: 10.1016/j.ijcard.2022.09.037

Podaci o odgovornosti

Sokhal, Balamrit Singh ; Matetić, Andrija ; Paul, Timir K. ; Velagapudi, Poonam ; Lambrinou, Ekaterini ; Figtree, Gemma A. ; Rashid, Muhammad ; Moledina, Saadiq ; Vassiliou, Vassilios S. ; Mallen, Christian ; Mamas, Mamas A.

engleski

Management and outcomes of patients admitted with type 2 myocardial infarction with and without standard modifiable risk factors

Background: Whilst it is known patients without standard modifiable cardiovascular risk factors (SMuRF ; hy-pertension, diabetes, hypercholesterolaemia, smoking) have worse outcomes in Type 1 acute myocardial infarction (AMI), the relationship between type 2 AMI (T2AMI) and outcomes in patients with and without SMuRF is unknown. This study aimed to determine the prevalence, characteristics and clinical outcomes of patients hospitalised with T2AMI based on the presence of SMuRF. Methods: Using the National Inpatient Sample, all hospitalizations with a primary discharge diagnosis of T2AMI were stratified according to SMuRF status (SMuRF and SMURF-less). Primary outcome was all-cause mortality while secondary outcomes were major adverse cardiovascular and cerebrovascular events (MACCE), major bleeding and ischemic stroke. Multivariable logistic regression was used to determine adjusted odds ratios (aOR) with 95% confidence intervals (95% CI). Results: Among 17, 595 included hospitalizations, 1345 (7.6%) were SMuRF-less and 16, 250 (92.4%) were SMuRF. On adjusted analysis, SMuRF-less patients had increased odds of all-cause mortality (aOR 2.43, 95% CI 1.83 to 3.23), MACCE (aOR 2.32, 95% CI 1.79 to 2.90) and ischaemic stroke (aOR 2.57, 95% CI 1.56 to 4.24) compared to their SMuRF counterparts. Secondary diagnoses among both cohorts were similar, with respiratory disorders most prevalent followed by cardiovascular and renal disorders. Conclusions: T2AMI in the absence of SMuRF was associated with worse in-hospital outcomes compared to SMuRF-less patients. There was no SMuRF-based difference in the secondary diagnoses with the most common being respiratory, cardiovascular, and renal disorders. Further studies are warranted to improve overall care and outcomes of SMuRF-less patients.

acute myocardial infarction ; Risk factors ; Outcomes ; National Inpatient Sample

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

371

2022.

391-396

objavljeno

0167-5273

1874-1754

10.1016/j.ijcard.2022.09.037

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost